These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2464269)

  • 1. Myelin basic protein as a possible marker for oligodendroglioma.
    Tanaka J; Hokama Y; Nakamura H
    Acta Pathol Jpn; 1988 Oct; 38(10):1297-303. PubMed ID: 2464269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of oligodendrogliomas: an analysis of multiple markers.
    Nakagawa Y; Perentes E; Rubinstein LJ
    Acta Neuropathol; 1986; 72(1):15-22. PubMed ID: 2435103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.
    Herpers MJ; Budka H
    Acta Neuropathol; 1984; 64(4):265-72. PubMed ID: 6391068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
    Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
    No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue.
    Hagel C; Stavrou DK
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):313-8. PubMed ID: 10476048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendroglioma with signet-ring cell morphology: a case report with an immunohistochemical and ultrastructural study.
    Mikami Y; Shirabe T; Hata S; Watanabe A
    Pathol Int; 1998 Feb; 48(2):144-50. PubMed ID: 9589479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
    Soichi O; Masanori N; Hideo T; Kazunori A; Nobuya I; Jun-ichi K
    Neurosurgery; 2007 Apr; 60(4):707-14; discussion 714. PubMed ID: 17415208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed oligodendroglioma and astrocytoma: fine structural and immunohistochemical studies of four cases.
    Kamitani H; Masuzawa H; Sato J; Kanazawa I
    J Neurol Sci; 1988 Feb; 83(2-3):219-25. PubMed ID: 2451711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GFAP-positive and myelin marker-positive glia in normal and pathologic environments.
    Dyer CA; Kendler A; Jean-Guillaume D; Awatramani R; Lee A; Mason LM; Kamholz J
    J Neurosci Res; 2000 May; 60(3):412-26. PubMed ID: 10797544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characteristics of GFAP-positive oligodendroglial tumours. Part II: ultrastructural study.
    Matyja E; Taraszewska A; Nagańska E; Zabek M
    Folia Neuropathol; 2001; 39(2):103-10. PubMed ID: 11680631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of myelin basic protein and glial fibrillary acidic protein genes in human glial brain tumors].
    Dmytrenko VV; Boĭko OI; Shostak KO; Bilets'kyĭ AV; Malysheva TA; Shamaiev MI; Kliuchka VM; Rozumenko VD; Zozulia IuP; Kavsan VM
    Tsitol Genet; 2009; 43(1):28-35. PubMed ID: 19663312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic characteristics of GFAP-immunopositive oligodendroglial tumours Part I: immunohistochemical study.
    Matyja E; Taraszewska A; Zabek M
    Folia Neuropathol; 2001; 39(1):19-26. PubMed ID: 11678347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
    Nutt CL; Betensky RA; Brower MA; Batchelor TT; Louis DN; Stemmer-Rachamimov AO
    Clin Cancer Res; 2005 Mar; 11(6):2258-64. PubMed ID: 15788675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocytic characteristics of oligodendroglioma. Fine structural and immunohistochemical studies of two cases.
    Kamitani H; Masuzawa H; Sato J; Kanazawa I
    J Neurol Sci; 1987 May; 78(3):349-55. PubMed ID: 3585407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of oligodendrocytic mRNAs in glial tumors: changes associated with tumor grade and extent of neoplastic infiltration.
    Landry CF; Verity MA; Cherman L; Kashima T; Black K; Yates A; Campagnoni AT
    Cancer Res; 1997 Sep; 57(18):4098-104. PubMed ID: 9307299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nogo-A expression in oligodendroglial tumors.
    Jung TY; Jung S; Lee KH; Cao VT; Jin SG; Moon KS; Kim IY; Kang SS; Kim HS; Lee MC
    Neuropathology; 2011 Feb; 31(1):11-9. PubMed ID: 20487307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for central nervous system glial cell plasticity in phenylketonuria.
    Dyer CA; Kendler A; Philibotte T; Gardiner P; Cruz J; Levy HL
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):795-814. PubMed ID: 8965095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunocytochemical comparison of the glia-associated proteins glial fibrillary acidic protein (GFAP) and S-100 protein (S100P) in human brain tumors.
    Kimura T; Budka H; Soler-Federsppiel S
    Clin Neuropathol; 1986; 5(1):21-7. PubMed ID: 3512139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors.
    Nakopoulou L; Kerezoudi E; Thomaides T; Litsios B
    J Neurooncol; 1990 Feb; 8(1):33-40. PubMed ID: 2319288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.